Pei-Yuan Lee, MD
8
0
0
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 8 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (8)
Autologous Bone Marrow Concentration for Avascular Necrosis of Femoral Head
Role: lead
Autologous Bone Marrow Concentration for Rotator Cuff Tear
Role: lead
Autologous Bone Marrow Concentration for Femoral Shaft Fracture Union
Role: lead
Autologous Bone Marrow Concentrate in Elective Tranforaminal Lumbar Interbody Fusion Surgery
Role: lead
Platelet-rich Plasma for Low Back Pain
Role: lead
Platelet Rich Plasma for Knee Osteoarthritis
Role: lead
Platelet-rich Plasma for Chronic Lateral Ankle Instability
Role: lead
Platelet-rich Plasma for Meniscus Repair
Role: lead
All 8 trials loaded